Oxford scientists raise VC investment to create variant-proof vaccines
Baseimmune, an early-stage UK biotech startup, is combining big data and biological expertise to predict how viruses will change and identify ‘future-proof’ antigens that will form the crucial elements of the next generation of vaccines. In order to further the development of its platform and start pre-clinical development in the